GPO Plus, Inc.
GPOX
$0.115
-$0.0055-4.56%
| Weiss Ratings | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.45 | |||
| Price History | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.12% | |||
| 30-Day Total Return | -3.70% | |||
| 60-Day Total Return | -10.41% | |||
| 90-Day Total Return | -16.13% | |||
| Year to Date Total Return | -5.73% | |||
| 1-Year Total Return | -0.38% | |||
| 2-Year Total Return | -62.32% | |||
| 3-Year Total Return | -91.98% | |||
| 5-Year Total Return | -90.15% | |||
| 52-Week High % Change | -46.44% | |||
| 52-Week Low % Change | 48.77% | |||
| Price | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.23 | |||
| 52-Week Low Price | $0.08 | |||
| 52-Week Low Price (Date) | Nov 10, 2023 | |||
| 52-Week High Price (Date) | Jun 06, 2023 | |||
| Valuation | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.32M | |||
| Enterprise Value | 9.63M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.11 | |||
| Earnings Per Share Growth | 9.48% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.34 | |||
| Price/Book (Q) | -0.87 | |||
| Enterprise Value/Revenue (TTM) | 2.67 | |||
| Price | $0.13 | |||
| Enterprise Value/EBITDA (TTM) | -2.82 | |||
| Enterprise Value/EBIT | -2.76 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 44.22M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 702 840 1020 | |||
| Address | 3571 East Sunset Road Las Vegas, NV 89120 | |||
| Website | gpoplus.com | |||
| Country | United States | |||
| Year Founded | 2016 | |||
| Profitability | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -96.70% | |||
| Profit Margin | -119.04% | |||
| Management Effectiveness | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -252.68% | |||
| Return on Equity | -- | |||
| Income Statement | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.74M | |||
| Total Revenue (TTM) | 3.74M | |||
| Revenue Per Share | $0.09 | |||
| Gross Profit (TTM) | 707.20K | |||
| EBITDA (TTM) | -3.55M | |||
| EBIT (TTM) | -3.62M | |||
| Net Income (TTM) | -4.46M | |||
| Net Income Avl. to Common (TTM) | -4.46M | |||
| Total Revenue Growth (Q YOY) | 941.68% | |||
| Earnings Growth (Q YOY) | -1.42% | |||
| EPS Diluted (TTM) | -0.11 | |||
| EPS Diluted Growth (Q YOY) | 22.48% | |||
| Balance Sheet | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 406.70K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 867.50K | |||
| Total Preferred Equity (Q) | 1.92 | |||
| Total Equity (Q) | -3.82M | |||
| Current Ratio (Q) | 0.177 | |||
| Book Value Per Share (Q) | -$0.13 | |||
| Total Assets (Q) | 1.24M | |||
| Total Current Liabilities (Q) | 4.90M | |||
| Total Debt (Q) | 2.81M | |||
| Total Liabilities (Q) | 5.06M | |||
| Total Common Equity (Q) | -5.74M | |||
| Cash Flow | GPOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -59.50K | |||
| Cash from Financing (TTM) | 1.84M | |||
| Net Change in Cash (TTM) | 182.50K | |||
| Levered Free Cash Flow (TTM) | 244.00K | |||
| Cash from Operations (TTM) | -1.60M | |||
